5-carboxamidotryptamine has been researched along with Glioblastoma in 1 studies
5-carboxamidotryptamine: agonist of 5-HT receptor; structure given in first source
Glioblastoma: A malignant form of astrocytoma histologically characterized by pleomorphism of cells, nuclear atypia, microhemorrhage, and necrosis. They may arise in any region of the central nervous system, with a predilection for the cerebral hemispheres, basal ganglia, and commissural pathways. Clinical presentation most frequently occurs in the fifth or sixth decade of life with focal neurologic signs or seizures.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mahé, C | 1 |
| Bernhard, M | 1 |
| Bobirnac, I | 1 |
| Keser, C | 1 |
| Loetscher, E | 1 |
| Feuerbach, D | 1 |
| Dev, KK | 1 |
| Schoeffter, P | 1 |
1 other study available for 5-carboxamidotryptamine and Glioblastoma
| Article | Year |
|---|---|
Functional expression of the serotonin 5-HT7 receptor in human glioblastoma cell lines.
Topics: 5-Methoxytryptamine; 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Blotting, Western; Cell Line, | 2004 |